$1B Current Price $3.78 NYSE: SA Seabridge Gold Market Cap $2B Current Price $18.77 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. ...
Created with Highcharts 7.2.2 关键数据 Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Bid Price and Ask Price The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount th...
看看Ingevity Corporation(纽约证券交易所代码:NGVT)的内在价值 关键见解根据两阶段股权自由现金流计算,Ingevity的预计公允价值为43.91美元。当前股价为47.56美元,这表明Ingevity的交易价格可能接近其公允价值 Simply Wall St05/30 23:10 你应该以54.00美元的价格调查英吉维蒂公司(纽约证券交易所代码:NGVT)吗? Ingev...
Ingevity Corporation Common Stock 预期*报告收益时间 10/29/2024 收盘后. 该报告将适用于本财政季度末 Sep 2024. 据 Zacks Investment Research 报告,根据 1 分析师预测,对该季度的每股收益*市场共识预测为 $0.6. 去年同一季度报告的每股收益为 $1.21. ...
Ingevity Corporation (NGVT.NYSE): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Ingevity Corporation | Nyse: NGVT | Nyse
ingevity公司(纽交所:NGVT)的良性创业板推动了其股价。 考虑到化学品行业中的近一半公司的市销率低于1倍,Ingevity公司(NYSE:纽交所)的市销率(或“P/S”)比率1倍可能看起来是一个相当吸引人的投资机会。 Simply Wall St07/13 21:03 评估ingevity:5位金融分析师的见解 在过去的三个月里,有5位分析师...
杰富瑞投资银行:上调Ingevity(NGVT.US)评级,由持有调整至买入评级, 目标价由52.00美元调整至62.00美元。 Ingevity(NGVT.US)公司简介:Ingevity Corp是美国一家化学品生产商。 该公司有两个业务部门,即性能化学品业务部门和性能材料业务部门。其大部分收入来自高性能化学品部门,该部门负责生产和销售特种化学品,这些...
Ingevity(NGVT.US):2022年Q2财报实现营收4.199亿美元,前值为3.584亿美元,预期值为4.097亿美元,超出市场预期2.50%;每股收益为1.73美元,前值为1.55美元,预期值为1.62美元,超出市场预期6.79%。 Ingevity(NGVT.US)公司简介:Ingevity Corp.从事特种化学品和碳材料的制造。它通过以下部门运作:高性能化学品和高性能材...
【BT机构股评】特殊化学品公司Ingevity股票评级上调 $Ingevity Corporation When Issued(NGVT)$ Loop Capital将特殊化学品公司Ingevity的评级从“持有”上调至“买入”,并将其目标价从64美元上调至76美元。该行认为,该公司的转型为优化遗留资产提供了一条途径,随着时间的推移这将有利于提高该公司的整体盈利能力。
Economic Risk RegionDeveloped Total Constituents3,234 Included Constituents3,105 Min-72.4% Max46.2% Median0.0% Mean-1.5% Standard Deviation11.2% You can find companies with similar debt paydown yield usingthis stock screener. All rights reserved.Terms Of Use...